Home > Journals > Minerva Endocrinology > Past Issues > Articles online first > Minerva Endocrinologica 2020 Oct 02

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

 

Minerva Endocrinologica 2020 Oct 02

DOI: 10.23736/S0391-1977.20.03290-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Insulin resistance and hepatic steatosis in type 1 diabetes mellitus and their association with diabetic chronic complications

Simona G. POPA 1 , Ana M. SIMION 2, Mariana SOARE 2, Doina ARCOMITA 3

1 Department of Diabetes, Nutrition and Metabolic Diseases, University of Medicine and Pharmacy Craiova, Romania; 2 Department of Diabetes, Nutrition and Metabolic Diseases, Emergency Clinical Hospital Craiova, Romania; 3 Department of Internal Medicine, Emergency Clinical Hospital Sibiu, Sibiu, Romania


PDF


AIMS: To evaluate insulin resistance and hepatic steatosis and their association with diabetes duration, control and chronic complications in patients with type 1 diabetes.
METHODS: We studied medical records of 181 consecutive hospitalized adults patients with type 1 diabetes. Estimated glucose disposal rate (eGDR), insulin sensitivity score (ISS), fatty liver index (FLI) and hepatic steatosis index (HSI) were calculated.
RESULTS: Patients in the 1st tertile of eGDR (<4.1 mg/kg-1-min-1) and ISS (<4.8) had higher prevalence of ischemic cardiovascular disease (ICVD) (p<0.001), hepatic steatosis, higher gamma glutamyl transpeptidase, HSI, FLI compared with participants from the 2nd and 3rd tertile of eGDR and ISS. Compared with those without steatosis, patients with ultrasound-diagnosed steatosis (30.5%) had a higher ISS (4.4±1.9 vs 6.3±2.4, p<0.001), eGDR (4.5±3.0 vs 5.8±2.7, p=0.01), FLI (72.5±25.1 vs 51.0±27.2, p<0.001), HSI (37.5±6.1 vs 35.2±4.7, p=0.03) and prevalence of ICVD (71.7 vs 45.7%, p=0.004) and retinopathy (69.6 vs 52.4 %, p=0.03). Factors independently associated with hepatic steatosis were only ICVD (OR 0.148, p<0.001), ISS (OR=2.584, p=0.029), aspartate aminotransferase (OR=1.025, p=0.038) and male gender (OR=2.726, p=0.016).
CONCLUSIONS: Insulin resistance and hepatic steatosis are common in type 1 diabetes and have a significant association with ICVD, independently of diabetes duration, control and insulin doses.


KEY WORDS: Type 1 diabetes mellitus; Insulin resistance; Diabetes chronic complications

top of page